Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In addition, a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) co-agonist, tirzepatide, has been recently developed for the treatment of type 2 diabetes and obesity (Jakubowska et al., 2024)
Learn how to choose the best weight loss injection for you
The medication requires ongoing use to maintain weight loss, as demonstrated in the SURMOUNT-4 trial, where discontinuation led to weight regain
Though it will likely take several months for the first generics to reach the market, theyll certainly drive prices down
US$ 29.78
US$ 26.18
US$ 26.58
US$ 23.52
